stockrow
Friday 6 November 2026
Export RCEL’s income statement to Excel — free account
Avita Medical Inc.
RCEL Healthcare Medical Devices
Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024.
- Revenue
- +53.1%
- EPS
- +56.9%
- Free cash flow
- +86.7%
- Total debt
- +7.13%
Quarter to September 2026, against a year earlier
16.60
0.92
+5.87%
Follow RCEL
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Jun '21 | Dec '20 | Jun '20 | Dec '19 | Jun '19 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 2 | — | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.34 | 5.16 | 6.86 | 4.68 | 21.39 | 17.45 | 22.42 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(11.21) | (4.65) | 0.01 | 3.97 | 13.90 | 26.51 | 16.65 | 33.18 | 56.99 | 42.97 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(32.20) | (16.38) | (4.60) | 1.17 | 9.47 | 11.12 | (2.12) | 2.05 | (23.16) | (12.52) |
Beneish M-Score |
(4.09) | (2.03) | (3.01) | 0.20 | — | — | — | — | — | — |
P/Operating CF |
(17.68) | (40.99) | (31.68) | (46.93) | 39.14 | (127.69) | (70.80) | (104.76) | (199.67) | 0.00 |
P/B ratio |
0.00 | 73.63 | 7.01 | 1.90 | 2.85 | 4.41 | 6.74 | 8.56 | 10.05 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 7.09 | 1.91 | 2.87 | 4.43 | 6.79 | 8.61 | 10.09 | 0.00 |
EV/Sales |
2.27 | 5.27 | 5.90 | 2.41 | 15.34 | 13.73 | 19.20 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(5.21) | (6.92) | (7.78) | (4.34) | (38.92) | (126.32) | (25.69) | (44.81) | (46.18) | 0.45 |
EV/FCF |
(4.92) | (5.80) | (7.48) | (4.20) | (38.01) | (107.07) | (24.09) | (44.34) | (44.31) | 0.43 |
Quick Ratio |
0.44 | 2.36 | 7.33 | 7.83 | 16.08 | 16.01 | 9.90 | 9.89 | 5.09 | 5.09 |
Current Ratio |
0.57 | 2.83 | 7.88 | 8.18 | 16.42 | 16.42 | 10.17 | 10.17 | 5.50 | 5.50 |
Net Debt/EBITDA |
(0.60) | (0.11) | 1.47 | 3.01 | 4.03 | 4.30 | 1.56 | 1.78 | 0.65 | 0.83 |
Debt/Assets |
76.22% | 53.00% | 35.66% | 0.93% | 1.26% | 0.00% | 2.98% | 0.00% | 0.15% | 0.15% |
Debt/Equity |
(2.58) | 9.39 | 0.81 | 0.01 | 0.01 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.05 | 0.67 | 0.48 | 0.31 | 0.23 | 0.28 | 0.17 | 0.26 | 0.21 | 0.25 |
Operating CF/Net income |
0.64 | 0.79 | 1.07 | 0.72 | 0.97 | 0.97 | 0.54 | 0.54 | 0.78 | 0.79 |
Capex/Depreciation |
(0.70) | (8.14) | (2.19) | (0.92) | (0.09) | (1.64) | 0.00 | (1.82) | 0.00 | (4.77) |
Interest Coverage |
(8.71) | (10.53) | (29.90) | (1,663.31) | (3,364.12) | (1,205.59) | (2,824.55) | (1,272.52) | (192.77) | (920.36) |
| 799.72% | (230.96%) | (52.89%) | (26.61%) | (22.98%) | (28.27%) | (58.05%) | (90.09%) | (117.92%) | (138.34%) | |
| (71.40%) | (64.64%) | (33.71%) | (23.83%) | (21.18%) | (25.57%) | (50.97%) | (77.66%) | (96.61%) | (114.36%) | |
ROIC |
(334.18%) | (324.79%) | 0.00% | (263.35%) | (142.98%) | (352.10%) | 0.00% | 0.00% | 0.00% | (1,478.09%) |
Return on Tangible Assets |
261.83% | (131.98%) | (38.17%) | (34.20%) | (22.74%) | (23.04%) | (56.50%) | (58.34%) | (118.91%) | (114.83%) |
Average Days of Receivables |
46.31 | 66.95 | 56.01 | 46.80 | 98.43 | 92.44 | 64.16 | 62.24 | 138.52 | 141.17 |
Research and Development Expense of Revenue |
29.10% | 31.69% | 41.52% | 40.26% | 50.69% | 50.69% | 59.32% | 64.25% | 186.39% | 186.39% |
Selling, General and Administrative Expense of Revenue |
112.43% | 142.24% | 130.88% | 131.44% | 126.78% | 126.78% | 346.59% | 341.66% | 462.84% | 463.54% |
Intangible Assets out of Total Assets |
0.10 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
13.29% | 21.01% | 16.72% | 20.33% | 12.27% | 19.38% | 0.00% | 115.59% | 0.00% | 35.31% |
Graham Net Nets |
(0.39) | (0.05) | 0.12 | 0.46 | 0.27 | 0.22 | 0.14 | 0.11 | 0.09 | 0.00 |
Graham Number |
4.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(50.55%) | (18.67%) | (10.28%) | (16.54%) | (8.62%) | (5.80%) | (8.80%) | (21.84%) | (12.64%) | (18.40%) |
Free Cash Flow Yield |
(34.36%) | (17.61%) | (11.49%) | (12.22%) | (1.89%) | (0.73%) | (3.55%) | (1.99%) | (2.04%) | 0.00% |
Revenue per Share |
2.57 | 2.48 | 1.98 | 1.38 | 1.29 | 1.29 | 0.70 | 0.70 | 0.44 | 0.43 |
Operating CF per Share |
(1.12) | (1.89) | (1.50) | (0.76) | (1.14) | (1.14) | (1.12) | (1.12) | (1.55) | (1.55) |
Capex per Share |
(0.06) | (0.35) | (0.05) | (0.02) | (0.01) | (0.05) | 0.00 | (0.04) | 0.00 | (0.10) |
Free Cash Flow per Share |
(1.18) | (2.25) | (1.55) | (0.78) | (1.15) | (1.19) | (1.12) | (1.16) | (1.55) | (1.65) |
Cash per Share |
0.65 | 1.39 | 3.51 | 3.17 | 4.89 | 4.89 | 3.64 | 3.64 | 1.61 | 1.64 |
Shareholders Equity per Share |
(0.60) | 0.17 | 1.94 | 3.39 | 5.10 | 5.10 | 3.57 | 3.57 | 1.65 | 1.71 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.60) | 0.17 | 1.94 | 3.39 | 5.10 | 5.10 | 3.57 | 3.57 | 1.65 | 1.71 |
Free Cash Flow |
(32.83) | (58.11) | (39.39) | (19.61) | (26.03) | (27.07) | (22.75) | (23.59) | (19.66) | (20.94) |
Working Capital |
(27.19) | 36.84 | 90.81 | 76.77 | 113.94 | 113.94 | 70.68 | 70.68 | 19.86 | 20.24 |
Capital Expenditures |
(1.64) | (9.17) | (1.38) | (0.52) | (0.13) | (1.17) | (0.85) | (0.85) | (1.28) | (1.28) |
Net Current Asset Value |
(37.55) | (18.21) | 41.42 | 73.93 | 111.48 | 111.48 | 68.33 | 68.33 | 19.39 | 20.20 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.14 | 0.03 | 0.02 | 0.00 | 0.04 | 0.00 | 0.06 | 0.00 | 0.23 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.27 | 0.11 | 0.34 | 0.47 | 0.49 | 0.49 | 0.26 | 0.34 | 0.21 | 0.20 |
Cash ROIC |
(73.76%) | (70.33%) | (22.14%) | (11.89%) | (11.41%) | (11.95%) | (15.30%) | (16.13%) | (47.62%) | (49.26%) |
Accounts Receivable Turnover |
6.86 | 6.60 | 8.28 | 5.60 | 3.82 | 5.90 | 5.78 | 6.31 | 2.61 | 1.79 |
Accounts Payable Turnover |
1.68 | 1.80 | 2.29 | 1.97 | 1.91 | 1.60 | 0.69 | 1.24 | 0.54 | 0.57 |
Inventory Turnover |
1.80 | 1.41 | 2.02 | 3.20 | 3.61 | 4.29 | 2.64 | 3.18 | 1.62 | 1.51 |
Average Days of Payables |
255.59 | 252.62 | 177.95 | 181.38 | 191.43 | 191.43 | 531.97 | 531.97 | 143.27 | 1,211.09 |
Days of Inventory on Hand |
197.59 | 291.75 | 262.54 | 128.39 | 101.05 | 101.05 | 138.12 | 138.12 | 223.14 | 227.39 |
Average Receivables |
10.44 | 9.74 | 6.05 | 6.15 | 7.64 | 4.96 | 2.47 | 2.26 | 2.11 | 3.07 |
Average Payables |
7.63 | 5.04 | 3.40 | 3.06 | 3.12 | 3.73 | 4.33 | 2.40 | 2.25 | 2.12 |
Average Inventory |
7.10 | 6.43 | 3.86 | 1.89 | 1.65 | 1.39 | 1.13 | 0.93 | 0.75 | 0.81 |
Average Assets |
68.05 | 95.68 | 104.95 | 111.88 | 125.50 | 103.98 | 82.46 | 54.12 | 26.03 | 21.64 |
Average Common Equity |
(6.08) | 26.78 | 66.90 | 100.20 | 115.66 | 94.03 | 72.40 | 46.65 | 21.32 | 17.89 |
Columns are period end dates · fundamentals updated 5 Nov 2026